| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -42.29M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ZNTL returned +92.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +183.3% |
| 1 year | +92.2% |
| 5 years | -94.4% |
| All-time high | $84.06 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ZNTL would be worth today ›No. Zentalis Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Zentalis Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol ZNTL.
Zentalis Pharmaceuticals, Inc. is part of the Healthcare sector.
Zentalis Pharmaceuticals, Inc. has a market cap of 362.12M USD, based on the latest quote.